IRIS International, Inc. Names David W. Gates, Ph.D. as Vice President, Quality and Regulatory Affairs

CHATSWORTH, Calif., Dec. 17, 2009 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that it has appointed David W. Gates, Ph.D., to the newly-created position of Vice President, Quality and Regulatory Affairs. Dr. Gates' primary focus will be the formulation and implementation of regulatory strategies for all company units, including Iris Diagnostics, Iris Molecular Diagnostics (IMD) and Iris Sample Processing (ISP) business units, as well as overseeing all U.S. and international regulatory filings, in support of the advancement of the Company's existing and emerging product pipeline.